Landauer (LDR) Receiving Somewhat Positive Media Coverage, Report Finds

News articles about Landauer (NYSE:LDR) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm rates the sentiment of news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Landauer earned a daily sentiment score of 0.18 on Accern’s scale. Accern also gave news headlines about the scientific and technical instruments company an impact score of 46.2568268274117 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Separately, Zacks Investment Research upgraded shares of Landauer from a “strong sell” rating to a “hold” rating in a research note on Wednesday, October 11th.

Shares of Landauer (NYSE LDR) remained flat at $$67.20 during trading hours on Friday. Landauer has a 12 month low of $41.00 and a 12 month high of $68.50. The company has a current ratio of 2.02, a quick ratio of 1.87 and a debt-to-equity ratio of 3.26. The firm has a market cap of $647.71, a P/E ratio of 35.00 and a beta of 1.28.

COPYRIGHT VIOLATION WARNING: This story was first published by Community Financial News and is the property of of Community Financial News. If you are accessing this story on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this story can be accessed at https://www.com-unik.info/2018/01/07/landauer-ldr-receiving-somewhat-positive-media-coverage-report-finds.html.

About Landauer

Landauer, Inc is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products.

Insider Buying and Selling by Quarter for Landauer (NYSE:LDR)

What are top analysts saying about Landauer? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Landauer and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit